Use of Lipid-Lowering Drugs and the Risk of Cataract: A Population-Based Nested Case-Control Study.

Bezin J, Mansiaux Y, Noize P, Salvo F, Bégaud B, Pariente A

Open source

DOI
10.1002/cpt.1176
Published
2019 Feb
Container
Clinical pharmacology and therapeutics
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cpt.1176,
  title = {Use of Lipid-Lowering Drugs and the Risk of Cataract: A Population-Based Nested Case-Control Study.},
  author = {Bezin J and Mansiaux Y and Noize P and Salvo F and Bégaud B and Pariente A},
  year = {2019},
  journal = {Clinical pharmacology and therapeutics},
  doi = {10.1002/cpt.1176},
  url = {https://doi.org/10.1002/cpt.1176}
}

RIS

TY  - JOUR
TI  - Use of Lipid-Lowering Drugs and the Risk of Cataract: A Population-Based Nested Case-Control Study.
AU  - Bezin J
AU  - Mansiaux Y
AU  - Noize P
AU  - Salvo F
AU  - Bégaud B
AU  - Pariente A
PY  - 2019
JO  - Clinical pharmacology and therapeutics
DO  - 10.1002/cpt.1176
UR  - https://doi.org/10.1002/cpt.1176
ER  - 

APA

J, B., Y, M., P, N., F, S., B, B., & A, P. (2019). Use of Lipid-Lowering Drugs and the Risk of Cataract: A Population-Based Nested Case-Control Study.. Clinical pharmacology and therapeutics. https://doi.org/10.1002/cpt.1176

Source records